--commercialization for clinical deployment.
I. INTRODUCTION
around the application of nonthermal plasma plume chemistries for a variety of clinical purposes. In this regard, APP differs from the topical use of plasma plumes onto the plasmas, such as jets, plumes, or dielectric barrier discharge systems. Ultimately fundamental plasma physics, life science research, and clinical medical applications all containing ions, radicals, and electrons. Nonthermal plasma indicates that the kinetic in minimal temperature increase from room temperature.
1 Plasma medicine approaches 2 in vitro -during surgical procedures, or for cutting during electrosurgery. Notably, many universities and institutes internationally are exploring the versatile plasma science and commercial clinical application. Many individual research groups and institutions have recognized the possibilities of plasma applications in health care. -versity, George Washington University, the Leibniz Institute, the Max Planck Institute, Nagoya University, Texas A&M University, and others. In addition to academic research, several companies specialize in plasma tools for use in electrosurgery, such as Bovie Medical Corporation, Olympus, Plasma Surgical, EP Technologies, and US Medical Innovations.
The AJ Drexel Nyheim Plasma Institute at Drexel University includes the Plasma discharge plasma plumes for sterilization, cancer treatment, bacterial inactivation, coagulation, angiogenesis, bone fusion, and a variety of dermal applications including -tions.
--ma-plume technology for disinfection, in vitro -tion of a proprietary hand-held plasma torch pen, the kINPen; they have three product direct dermal treatment of animal or human models. Notably, approaches 1-3 include in vitro in vivo 3-10 -ment, [11] [12] [13] [14] [15] [16] [17] [18] [19] dermatology, 20,21 22 -
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tions published by each group are highlighted.
II. METHODS OF PLASMA DISCHARGE IN SOLUTION
species to solution can result in in situ treatment. Plasma systems represent an attractive --nisms are employed for in situ disinfection and organic compound oxidation. [141] [142] [143] As such, a variety of plasma generation systems, including pulsed corona discharge, dielec-144 environmental, chemical, material functionalization, synthesis, and industrial clean-up applications. 145, 146 fundamental physics of various systems; 147 There are many different methods of producing plasma discharge in solution, but A. Surface-Water Discharges
Gliding Arc Discharge
The gliding arc discharge method features the formation and movement of an arc dis- The most common version of this plasma discharge method is the point-to-plane -generation. This method is effective because the air surrounding the point electrode acts -ating plasma more readily. The disadvantage is that this approach creates essentially a the system must rely on diffusion or convection. This presents a problem for scaleand the ground in the gas phase above produces larger amounts of hydrogen peroxide 150 scalable for commercial use. spreading the current density across multiple electrodes is the potential of reduced heat produced by plasma on a g kW -1 hr -1 basis, the nature of their design makes scale-up to -drical system, have the greatest potential for scaling up to a more useful level and also -ally, more recent innovations such as electrode coatings or multiple parallel electrode 142 Overall, many different electrical discharge methods are available for preparing plasmato be thoroughly investigated for APP applications.
B. Direct Discharge Methods

Point-to-Plane Liquid Discharge
III. AQUEOUS PLASMA CHEMISTRY
to oxidant species formation, composition, reactivity, and stability not only presents an -loring oxidant chemistries such that different therapeutic processes can be targeted. As such, the tunable combination of oxidant species in solution enables plasma-activated a single oxidant species alone or non-plasma-generated mixes of multiple oxidant species. Many fundamental studies have been performed to determine the physical propspecies prepared via electrical discharges in solution; 143, 144, 157, 158 
A. Feed Gas
As described previously, OH , H , and O production is enhanced for gas bubble con-
144
Additionally, H is instead the major radical product. As such, to enhance the formation of RNS, N 2 -containing feed gas sources can be used, such as pure N 2 to maximize RNS 
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target therapeutic oxidant species that are favored for therapeutic action. For instance, to target a more highly oxidizing plasma-treated solution, oxygen or air feed gas can be
B. Plasma System and Power Input
In general, the concentration of primary reactive species formed in a plasma discharge, -able effects that may occur, such as thermal heating. Other studies indicate a linear increase in O 3 3 concentra-168 Notably, certain plasma setups, such as plasma discharge above solution, experience diffusion limitations that limit the concentration of plasma species -tion, such as systems that involve plasma discharge into gas bubbles.
151 To maximize the 3 -ble for therapeutic activity, as described in later sections; thus, O 3 levels can be increased by increasing applied voltage. As more is learned about the cellular mechanism of action The plasma exposure time --143 Additionally, because the plasma chemistry is so diverse and complex, plasma species discussed above have been characterized in different plasma plume and is still needed to understand the complex reactivity and abundance of species present in activated solutions prepared by multiple different discharge methods. Disinfection has been demonstrated to be more effective using PAW versus mock soluof the plasma activation that leads to disinfection. These solutions also have demon-indicate that the presence of certain additives can extend the shelf life on the order of solutions for the best disenfection results.
C. Solution Composition
IV. APP APPLICATIONS
B. Cell Proliferation Related to Wound Healing
The application of direct plasma plumes to dermal tissues has been of interest to promote - 88 In addition to the dermal ap--using a dielectric barrier discharge system on porcine aortic endothelial cells in the 111, 116 General direct plasma plume 111, 116 apoptotic mechanisms that involve oxidative stress, DNA damage, 27, 41, 89, 118, 132 and mitochondrial dysfunction. 24, 30, 118 These references, and others cited in Table 1 , have generand invasiveness, clonogenicity, dose-dependent induction of apoptosis and/or necrosis, cell cycle arrest, senescence, induction of intra-or extra-cellular ROS production, and been directly correlated to the plasma treatment time as the most critical parameter, alsuch as H 2 O 2 and NO , 35, 194 plasmas for cancer treatment is less likely to result in the development of drug resistance 195 stress on cancer cells, as induced by various ROS, is critical for the selective treatment of cancer cells. 196 balance of ROS generation via pro-oxidants and elimination via antioxidants to maintain basal ROS levels for proper physiological function. In general, moderate increases in ROS levels can promote helpful processes, such as cell proliferation and differentiation.
not for normal cells. Normal cells can be exposed to a given amount of exogenous ROS
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The basal ROS levels are higher for cancer cells compared to normal cells, thus applica-stress due to reserves of antioxidants to prevent cellular ROS levels from reaching the fatal threshold. Cancer cells already exist at an increased ROS generation due to metacharacteristics, including cancer cell proliferation, disruption of cell death signaling, and chemoresistance. When both cancer and normal cells are exposed to exogenous ROS past the ROS threshold. Overall, cancer cells are more vulnerable to external oxidative stress than normal cells, thus enabling selective cancer cell destruction in the presence -cer. Such ROS-mediated approaches to targeting cancer treatment may overcome issues geometry makes it most suitable for treating surface sites, such as skin cancer. One in vivo or in vitro a range of cancer types and has been attributed to ROS effects. In general, the potency of the bioactive solution is related to plasma exposure time, but the effects also vary by are dependent upon the amino acid compositions of the media, and temperature also has an impact on the stability of the solution during storage.
V. FUTURE DIRECTIONS IN APP
Together, much of the aforementioned research has highlighted the importance of multiple of plasma species appears to be more potent than any individual chemical component or -lights the importance of such a synergistic, multifaceted therapeutic approach. Because -chemistry can be tuned to favor the species and solution conditions that are most effective. A recent book chapter by von Woedtke discussed one of the main hurdles in the -curacy.
174 For plasma-prepared bioactive solutions to succeed in commercial applicathat are selective and sensitive for a given species of interest, thus enabling a detailed understanding of the plasma-solution mechanisms that give rise to therapeutic effects. In theory, the use of plasma-activated solutions represents more versatile routes sites through the bloodstream. Plasma plumes have mostly been suggested for surface --cerns, 47, 198, 199 layers. 75 Direct application of plasma plume species to a prostate tumor site has been suggested via transperineal administration; 19 easily accessible as the prostate is rectally. Thus, if stability and composition hurdles can site of interest, such as a tumor. It is also possible to sell small plasma devices for on-site generation of plasma-prepared bioactive solutions in a systematic and reproducpatient administration.
tions described above. Plasma-treated solutions have been implicated in electrosurgery applications, 159,200 -201 to oxidative stress, such as neurological, cardiovascular, and gastrointestinal disorders 202 Thus, APP may eventually be applied to a variety of indications, such as cardiovascular disease, diabetes, asthma, stroke, arthritis, and renal failure. As an example, a variety of NO x species are involved - 90 These combined and enhanced chemotherapy applications can certainly be applied to plasma-activated solutions.
--ous chemistry yields a multitude of plasma species that perform more effectively than any single oxidant species alone. Furthermore, the transfer of plasma species to the -thoroughly understand the plasma science, chemistry, composition, and mechanism of -tive chemotherapies. vier; 42: 179-292. -nisms. Plasma Chem Plasma Process. 2013; 33:1-15. reactions from plasma/gas phase reactions. Proc ESA Annual Meeting on Electrostatics; 2013. p. 1-8.
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tric barrier discharge plasma. PLoS ONE. 2013;8:e70840. 150. Locke BR, Sato M, Sunka P, Hoffmann MR, Change J. Electrohydraulic discharge and nonthermal 151. Sun B, Sato M, Clements JS. Optical study of active species produced by a pulsed streamer corona -
